UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 688/2025

Jul 28, 2025·EP4074373 Unitary patent · MRI-SAFE DISK MAGNET FOR IMPLANTS

Follow
Case details
Status
Case Closed (Settled)
Action
Infringement
Category
Main infringement action
Parties
Respondents
Representatives
  • Adrian Crespo Velasco
Division
Hamburg LD
Judges
Technology
  • Instruments
    Medical technology
Language
English
First decided
Aug 25, 2025
Last decision
Sep 30, 2025
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
Hamburg LDLockedLocked
Judge Sabine KlepschLockedLocked
Judge Stefan JohanssonLockedLocked
Judge Stefan SchillingLockedLocked

At the UPC: MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (14 cases)·Zhejiang Nurotron Biotechnology Co., Ltd. (2 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 1 other proceedings

UPC CFI 514/2025

13 other defendants litigating the same or a related patent

UPC CoA 175/2025·UPC CoA 176/2025·UPC CoA 177/2025·UPC CoA 178/2025·UPC CFI 65/2025 and 8 more

Start a free trial to see how each one ended.

More cases: Hamburg LD·2025

Decisions
  • 2025-09-30
    Infringement ActionPublic

    Summary: The Hamburg Local Division confirmed the settlement between MED-EL Elektromedizinische Geräte and Zhejiang Nurotron Biotechnology / Nurotron Global SARL in the infringement action concerning EP 4 074 373, recording the settlement as an enforceable court decision under R. 365 RoP with the details remaining confidential.

    Show the legal issues (2)
    • Settlement confirmation (Art. 79 UPCA, R. 365 RoP)
    • Confidentiality of settlement terms
  • 2025-08-25
    Public

    Summary: The Hamburg Local Division ruled that authority to represent a defendant in provisional measures proceedings does not automatically extend to receiving service of a statement of claim in subsequent infringement proceedings, and that service on non-EU defendants must follow Rule 274 RoP.

    Show the legal issues (3)
    • Service of claim
    • Authority of representative (Rule 213 RoP)
    • Service on non-EU party (Rule 274 RoP)
Documents
Document titleDatePublic
Cover sheet2025-10-20Not public
Application2025-10-20Not public
Receipt2025-10-20Not public
Case closed2025-10-20Not public
Other Documents2025-10-20Not public
Decision2025-09-30Not public
Decision2025-09-30Not public
Decision2025-09-30Public
Receipt2025-09-18Not public
Receipt2025-09-18Not public
Receipt2025-09-18Not public
R. 262.22025-09-18Not public
Request R. 9 RoP2025-09-18Not public
Exhibit HL 29 nonredacted2025-09-18Not public
Application R. 365 RoP2025-09-18Not public
Exhibit HL 29 nonredacted2025-09-18Not public
Receipt2025-09-15Not public
Request pursuant to R. 356 RoP2025-09-14Not public
Request pursuant to R. 356 RoP2025-09-14Not public
Receipt2025-09-12Not public
MEDEL vs Nurotron Application R. 365 RoP2025-09-12Not public
Exhibit HL 292025-09-12Not public
Acknowledgement of access to case2025-09-12Not public
Notification Of Service2025-09-11Not public
Confirmation2025-09-11Not public
Letter-for-Service2025-08-26Not public
Headnote-and-Keywords2025-08-25Not public
Procedural Order2025-08-25Public
Acknowledgement of access to case2025-08-22Not public
Notification Of Service2025-08-19Not public
Receipt of service2025-08-19Not public
Receipt of service2025-08-19Not public
Panel-Appointment2025-08-13Not public
Letter-for-Service2025-08-11Not public
Comments pursuant to RoP 2642025-08-08Not public
Document from EPO2025-08-06Not public
EPO_Communication_check_Outcome2025-08-06Not public
Document from EPO2025-08-06Not public
EPO_Communication_check_Outcome2025-08-06Not public
Document from EPO2025-08-06Not public
EPO_Communication_check_Outcome2025-08-06Not public
EPO_Communication_check_Outcome2025-08-06Not public
EPO_Communication_check_Outcome2025-08-06Not public
Document from EPO2025-08-05Not public
Document from EPO2025-08-05Not public
Document from EPO2025-08-05Not public
EPO_Communication_check_Outcome2025-08-05Not public
EPO_Communication_check_Outcome2025-08-05Not public
Document from EPO2025-08-05Not public
Document from EPO2025-08-05Not public
Document from EPO2025-08-05Not public
Anhoerung2025-08-01Not public
Panel-Appointment2025-08-01Not public
EPO-Request-for-case-pending2025-08-01Not public
Receipt2025-08-01Not public
Formal-checks_Notification-of-positive-outcome2025-08-01Not public
Exhibit HL 102025-07-31Not public
Exhibit HL 13.32025-07-31Not public
Exhibit HL 252025-07-31Not public
Exhibit HL 12b2025-07-31Not public
Exhibit HL 172025-07-31Not public
Exhibit HL 82025-07-31Not public
Exhibit HL 13.72025-07-31Not public
Exhibit HL 72025-07-31Not public
Exhibit HL 13.82025-07-31Not public
Exhibit HL 212025-07-31Not public
Exhibit HL 92025-07-31Not public
Exhibit HL 13.12025-07-31Not public
Exhibit HL 12025-07-31Not public
Exhibit HL 152025-07-31Not public
Exhibit HL 12a2025-07-31Not public
Exhibit HL 242025-07-31Not public
Exhibit HL 32025-07-31Not public
Exhibit HL 3a2025-07-31Not public
MED-EL vs Nurotron - Infringement action EP'3732025-07-31Not public
Exhibit HL 62025-07-31Not public
Exhibit HL 262025-07-31Not public
Exhibit HL 112025-07-31Not public
Exhibit HL 272025-07-31Not public
Exhibit HL 232025-07-31Not public
Exhibit HL 13.22025-07-31Not public
Exhibit HL 42025-07-31Not public
Exhibit HL 13.92025-07-31Not public
Exhibit HL 13.62025-07-31Not public
MEDEL formal response to the request for amendments2025-07-31Not public
Exhibit HL 162025-07-31Not public
Exhibit HL 142025-07-31Not public
Exhibit HL 192025-07-31Not public
Exhibit HL 22025-07-31Not public
Exhibit HL 13.52025-07-31Not public
Exhibit HL 14a2025-07-31Not public
Exhibit HL 222025-07-31Not public
Exhibit HL 202025-07-31Not public
Exhibit HL 52025-07-31Not public
Exhibit HL 182025-07-31Not public
Exhibit HL 282025-07-31Not public
Exhibit HL 25a2025-07-31Not public
Exhibit HL 13.42025-07-31Not public
Formal-checks_Request-for-correction2025-07-30Not public
Acknowledgement-of-lodging2025-07-28Not public
Exhibit HL 162025-07-28Not public
Exhibit HL 42025-07-28Not public
Exhibit HL 212025-07-28Not public
Exhibit HL 13.62025-07-28Not public
Exhibit HL 13.52025-07-28Not public
Exhibit HL 72025-07-28Not public
Exhibit HL 112025-07-28Not public
Exhibit HL 282025-07-28Not public
Exhibit HL 32025-07-28Not public
Exhibit HL 202025-07-28Not public
Exhibit HL 272025-07-28Not public
Exhibit HL 262025-07-28Not public
Exhibit HL 192025-07-28Not public
Exhibit HL 92025-07-28Not public
Exhibit HL 62025-07-28Not public
Exhibit HL 82025-07-28Not public
Exhibit HL 3a2025-07-28Not public
Exhibit HL 12b2025-07-28Not public
Exhibit HL 172025-07-28Not public
Exhibit HL 13.42025-07-28Not public
MED-EL vs Nurotron - Infringement action EP'3732025-07-28Not public
Exhibit HL 12025-07-28Not public
Exhibit HL 13.32025-07-28Not public
Exhibit HL 252025-07-28Not public
Exhibit HL 13.22025-07-28Not public
Exhibit HL 12a2025-07-28Not public
Exhibit HL 102025-07-28Not public
Exhibit HL 22025-07-28Not public
Exhibit HL 13.92025-07-28Not public
Exhibit HL 14a2025-07-28Not public
Exhibit HL 25a2025-07-28Not public
Exhibit HL 182025-07-28Not public
Exhibit HL 13.12025-07-28Not public
Exhibit HL 142025-07-28Not public
Exhibit HL 52025-07-28Not public
Exhibit HL 152025-07-28Not public
Exhibit HL 232025-07-28Not public
Exhibit HL 222025-07-28Not public
Exhibit HL 242025-07-28Not public
Exhibit HL 13.72025-07-28Not public
Exhibit HL 13.82025-07-28Not public
Coverage: Thin.Reasoning extracted with limited coverage — see decisions tab for full text.
Plain-English summary

MED-EL's infringement action against Zhejiang Nurotron Biotechnology and Nurotron Global SARL concerning EP 4 074 373 (MRI-safe disk magnet for cochlear implants) was resolved by settlement, with the Hamburg Local Division confirming the settlement as an enforceable court decision under R. 365 RoP while keeping the settlement terms confidential.

Accepted arguments
What the court agreed with — by party.

No accepted arguments captured.

Rejected arguments
What the court did not agree with — and why.

No rejected arguments captured.

Key legal principles
Doctrines and rules cited in the reasoning.
Court may confirm a settlement and render it enforceable as a final decision (Art. 79 UPCA; R. 365 RoP)Settlement details may be kept confidential by court order (R. 365.2-365.3 RoP; R. 262.2 RoP)

Browse other cases on this principle.